Bifidobacterium bifidum Strain BB1 Inhibits Tumor Necrosis Factor-α-Induced Increase in Intestinal Epithelial Tight Junction Permeability via Toll-Like Receptor-2/Toll-Like Receptor-6 Receptor Complex-Dependent Stimulation of Peroxisome Proliferator-Activated Receptor γ and Suppression of NF-κB p65

Am J Pathol. 2024 Sep;194(9):1664-1683. doi: 10.1016/j.ajpath.2024.05.012. Epub 2024 Jun 15.

Abstract

Bifidobacterium bifidum strain BB1 causes a strain-specific enhancement in intestinal epithelial tight junction (TJ) barrier. Tumor necrosis factor (TNF)-α induces an increase in intestinal epithelial TJ permeability and promotes intestinal inflammation. The major purpose of this study was to delineate the protective effect of BB1 against the TNF-α-induced increase in intestinal TJ permeability and to unravel the intracellular mechanisms involved. TNF-α produces an increase in intestinal epithelial TJ permeability in Caco-2 monolayers and in mice. Herein, the addition of BB1 inhibited the TNF-α increase in Caco-2 intestinal TJ permeability and mouse intestinal permeability in a strain-specific manner. BB1 inhibited the TNF-α-induced increase in intestinal TJ permeability by interfering with TNF-α-induced enterocyte NF-κB p50/p65 and myosin light chain kinase (MLCK) gene activation. The BB1 protective effect against the TNF-α-induced increase in intestinal permeability was mediated by toll-like receptor-2/toll-like receptor-6 heterodimer complex activation of peroxisome proliferator-activated receptor γ (PPAR-γ) and PPAR-γ pathway inhibition of TNF-α-induced inhibitory kappa B kinase α (IKK-α) activation, which, in turn, resulted in a step-wise inhibition of NF-κB p50/p65, MLCK gene, MLCK kinase activity, and MLCK-induced opening of the TJ barrier. In conclusion, these studies unraveled novel intracellular mechanisms of BB1 protection against the TNF-α-induced increase in intestinal TJ permeability. The current data show that BB1 protects against the TNF-α-induced increase in intestinal epithelial TJ permeability via a PPAR-γ-dependent inhibition of NF-κB p50/p65 and MLCK gene activation.

MeSH terms

  • Animals
  • Bifidobacterium bifidum* / metabolism
  • Bifidobacterium bifidum* / physiology
  • Caco-2 Cells
  • Humans
  • Intestinal Mucosa* / metabolism
  • Intestinal Mucosa* / microbiology
  • Mice
  • Mice, Inbred C57BL
  • Myosin-Light-Chain Kinase* / metabolism
  • PPAR gamma* / metabolism
  • Permeability* / drug effects
  • Probiotics / pharmacology
  • Tight Junctions* / metabolism
  • Toll-Like Receptor 2* / metabolism
  • Toll-Like Receptor 6
  • Transcription Factor RelA* / metabolism
  • Tumor Necrosis Factor-alpha* / metabolism

Substances

  • Myosin-Light-Chain Kinase
  • PPAR gamma
  • Toll-Like Receptor 2
  • Transcription Factor RelA
  • Tumor Necrosis Factor-alpha
  • Toll-Like Receptor 6